EUVIMEDEUVIMED entdecken
Crossref

Peritoneal and Pleural Drains in Pediatric Hematopoietic Cell Transplant Recipients with Veno-Occlusive Disease are Safe and Do Not Adversely Impact Clinical Outcomes

Hemalatha G Rangarajan, Vinita B Pai, Joseph R Stanek, Cassandra Rush, Jeffrey Naples, Misti Drope, Veronika Polishchuk, Rolla Abu-Arja, Rajinder Ps Bajwa

Hematology/Oncology and Stem Cell Therapy · 2023

DOI: 10.56875/2589-0646.1066 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hematology/Oncology and Stem Cell Therapy, 2023. Verfasst von Hemalatha G Rangarajan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Hematology, Oncology, Blood and Marrow Transplant Transplant, Nationwide Children's Hospital, Columbus, OH, USA. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Hepatic Veno-Occlusive Disease. Die Arbeit nennt 4 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is a lack of data on the safety and efficacy of peritoneal drain (PD) and chest tube (CT) in the management of effusions in stem cell transplant recipients with veno-occlusive disease (VOD). In this retrospective pediatric study, clinical outcomes and health resource utilization (HRU) were compared in 32 patients with VOD who had a PD (PD+) post-HCT versus 27 patients who did not (PD-). Nine patients also had a CT (7 PD+ and 2 PD-). PD + patients were more likely than PD-patients to have received myeloablative conditioning (100% vs. 85.2%; p = 0.04) and have severe or very severe VOD (100% vs. 56% p < 0.01). Mechanical obstruction (38%) and hypotension (38%) were common complications, and 13% developed peritonitis. While the frequencies of cardiac dysfunction and acute kidney injury were comparable between both groups, respiratory support and its median duration were higher in PD + patients. The hospital and intensive care unit length of stay, albumin use, and the duration of defibrotide and albumin therapy was significantly longer in PD + patients. At a median follow-up of 1.04 years (range:0.03–14.6), the 2-year overall survival was similar in both groups (53.8% vs. 51.5%; p = 0.73). Although PD use was similar between 1995 and 2007 vs. 2008–2021; (47% vs. 58%; p = 0.65), day+100 mortality was improved in recent years (53.3% vs. 17.8%; p = 0.01), coinciding with the use of defibrotide (0% vs. 84%; p < 0.01). PD in pediatric patients with VOD post-HCT, although associated with increased HRU, was safe when clinically indicated and did not adversely impact clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationHepatic Veno-Occlusive DiseaseChildHumansRetrospective StudiesTransplant RecipientsPolydeoxyribonucleotides

Substanzen

Polydeoxyribonucleotides

Autor:innen und Institutionen

  • Division of Pediatric Hematology, Oncology, Blood and Marrow Transplant Transplant, Nationwide Children's Hospital, Columbus, OH, USA.
  • Departments of Pediatrics, The Ohio State University, Columbus, OH, USA.
  • College of Pharmacy, The Ohio State University, Columbus, OH, USA.
  • Pharmacy, Nationwide Children's Hospital, Columbus, OH, USA.
  • Biostatistics Resource at Nationwide Children's Hospital, Columbus, OH, USA.
  • Department of Critical Care Medicine, Nationwide Children's Hospital, Columbus, OH, USA.

Zitieren

APA

Rangarajan, H. G., Pai, V. B., Stanek, J. R., Rush, C., Naples, J., Drope, M., Polishchuk, V., Abu-Arja, R., & Bajwa, R. P. (2023). Peritoneal and Pleural Drains in Pediatric Hematopoietic Cell Transplant Recipients with Veno-Occlusive Disease are Safe and Do Not Adversely Impact Clinical Outcomes. Hematology/Oncology and Stem Cell Therapy. https://doi.org/10.56875/2589-0646.1066

Vancouver

Rangarajan HG, Pai VB, Stanek JR, Rush C, Naples J, Drope M, et al. Peritoneal and Pleural Drains in Pediatric Hematopoietic Cell Transplant Recipients with Veno-Occlusive Disease are Safe and Do Not Adversely Impact Clinical Outcomes. Hematology/Oncology and Stem Cell Therapy. 2023. doi:10.56875/2589-0646.1066

BibTeX
@article{Rangarajan2023,
  author = {Rangarajan, Hemalatha G and Pai, Vinita B and Stanek, Joseph R and Rush, Cassandra and Naples, Jeffrey and Drope, Misti and Polishchuk, Veronika and Abu-Arja, Rolla and Bajwa, Rajinder Ps},
  title = {Peritoneal and Pleural Drains in Pediatric Hematopoietic Cell Transplant Recipients with Veno-Occlusive Disease are Safe and Do Not Adversely Impact Clinical Outcomes},
  journal = {Hematology/Oncology and Stem Cell Therapy},
  year = {2023},
  doi = {10.56875/2589-0646.1066}
}
Kostenlos starten →